Commentary on “Apabetalone, a BET protein inhibitor, inhibits kidney damage in diabetes by preventing pyroptosis via modulating the P300/H3K27ac/PLK1 axis”

Journal article

Open access

Peer reviewed

Kaiqing Li, Xue Xia, Tong Fu and Ying Tong

Pharmacological Research, Vol.208, p.107350

10/01/2024

PMID: 39153709

Abstract

Apabetalone

BET protein inhibitor

Diabetic kidney injury

Pyroptosis

Therapy

url

https://doi.org/10.1016/j.phrs.2024.107350View

Published (Version of record) Open

1 Record Views

Title: Commentary on “Apabetalone, a BET protein inhibitor, inhibits kidney damage in diabetes by preventing pyroptosis via modulating the P300/H3K27ac/PLK1 axis”
Creators: Kaiqing Li - Heilongjiang University of Chinese Medicine
Xue Xia - Heilongjiang University of Chinese Medicine
Tong Fu - Brandeis University
Ying Tong - First Affiliated Hospital of Heilongjiang University of Chinese Medicine
Publication Details: Pharmacological Research, Vol.208, p.107350
Grant note: Heilongjiang University of Chinese Medicine (http://data.elsevier.com/vocabulary/SciValFunders/501100009009) 15041180133 / Integrated Traditional Chinese and Western Medicine Discipline Development Fund
Identifiers: 9924550662701921
Academic Unit: Department of Biology
Language: English
Resource Type: Journal article